Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc (NQ: AMED )

95.49 +0.89 (+0.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amedisys Inc

< Previous 1 2 3 4 Next >
Amedisys: Q3 Earnings Insights
Amedisys (NASDAQ:AMED) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amedisys missed estimated... 
Via Benzinga
Preview: Amedisys's Earnings
Amedisys (NASDAQ:AMED) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Amedisys will... 
Via Benzinga
Expert Ratings for Amedisys
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where Amedisys Stands With Analysts
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter: 
Via Benzinga
University of Arkansas for Medical Sciences (UAMS) Announces a Partnership with Amedisys and Contessa, Creating a Comprehensive Care at Home Suite of Services
From Amedisys, Inc.
Via GlobeNewswire
6 Analysts Have This to Say About Amedisys
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Analyst Ratings for Amedisys
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter: 
Via Benzinga
7 Analysts Have This to Say About Amedisys
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter: 
Via Benzinga
Analyst Ratings For Amedisys
Over the past 3 months, 11 analysts have published their opinion on Amedisys (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
Upgrades 
Via Benzinga
What 9 Analyst Ratings Have To Say About Amedisys
Over the past 3 months, 9 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Recap: Amedisys Q2 Earnings
Amedisys (NASDAQ:AMED) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amedisys beat estimated earnings by... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022
Upgrades 
Via Benzinga
67 Biggest Movers From Yesterday
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital. 
Via Benzinga
Stephens & Co. Maintains Equal-Weight Rating for Amedisys: Here's What You Need To Know
Stephens & Co. has decided to maintain its Equal-Weight rating of Amedisys (NASDAQ:AMED) and lower its price target from $155.00 to $125.00. Shares of Amedisys are trading down 12.59% over the last 24... 
Via Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,. 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Goldman Sachs cut SunPower Corporation. (NASDAQ: SPWR) price target from $19 to $13. SunPower shares fell 3.1% to $17.37 in pre-market trading. 
Via Benzinga
Analyst Ratings for Amedisys
Over the past 3 months, 5 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... 
Via Benzinga
Where Amedisys Stands With Analysts
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
Upgrades According to 86 Research, the prior rating for NetEase Inc (NASDAQ:NTES) was changed from Hold to Buy. For the fourth quarter, NetEase had an EPS of $1.56,... 
Via Benzinga
Amedisys: Q4 Earnings Insights
Amedisys (NASDAQ:AMED) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
The U.S. Home Health Care Industry Is Reportedly Booming As Seniors Overwhelmingly Want To Live At Home
Photo by Kampus Production from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice... 
Via Benzinga
This Company Just Made a Possibly Lucrative Acquisition — What's Next?
Photo by Ccfb on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The global... 
Via Benzinga
10 Bargain Stocks to Buy After Falling 30% in 2021
If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill. 
Via InvestorPlace
This Home Medical Company Looks to Be Moving Fast — What's Next?
Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... 
Via Benzinga
Best Undervalued Health Care Companies You Never Heard Of
Health care is a gigantic industry and global spending is expected to rise at a 3.9% compound annual growth rate by 2024. Here are three health care stocks that look interesting. 
Via Talk Markets
This Industry, Important for Quality of Life, Is Big Business
Photo by Hush Naidoo Jade Photography on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... 
Via Benzinga
Global Home Medical Equipment Market Size Is Estimated To Reach $56 Billion By 2027
Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – Over the last few years, and with the ‘help’ of the pandemic, home health care medical equipment industry has surged. Home... 
Via FinancialNewsMedia
What 12 Analyst Ratings Have To Say About Amedisys
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within t... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.